| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2874175 | The Annals of Thoracic Surgery | 2013 | 9 Pages |
Abstract
Chemoradiotherapy carries a significant morbidity profile. However, high-dose neoadjuvant radiation is not associated with increased postoperative morbidity or mortality relative to standard-dose radiation in patients selected for anatomic resection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christopher W. MD, Mark S. MD, Stephen D. MD, Claude MD, Francis C. MD, Kenneth R. MD, K. Robert MD, Dennis A. MD, PhD,